Kathleen A Hazlewood
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Kathleen A Hazlewood has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Carlos Alberto Alvarez
Jerry H. Hodge School of Pharmacy and Center of Excellence in Real-World Evidence, Texas Tech University Health Sciences Center, Dallas, USA
2 shared publications - Christopher Giuliano
Wayne State University
2 shared publications - Christopher Raymond Frei
University of Texas at Austin
2 shared publications - Krystal K. Haase
Department of Pharmacy Practice, Texas Tech University Health Sciences Center, School of Pharmacy, Amarillo, USA
2 shared publications - Nicolas A Forcade
Division of Pharmacotherapy, University of Texas, Austin, USA
2 shared publications - Roger Bedimo
Division of Infectious Diseases, University of Texas Southwestern Medical Center , Dallas, Texas
2 shared publications
Latest Publications
- Open Access
- 13 February 2013
- Published by Springer Nature in BMC Pharmacology and Toxicology
- Vol. 14 (1) , 12
Empiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study
Previous studies have established a correlation between vancomycin troughs and nephrotoxicity. However, data are currently lacking regarding the effect of guideline-recommended weight-based dosing on nephrotoxicity in methicillin-resistant Staphylococcus aureus bacteremia (MRSAB).
- 13 February 2013
- Published by Springer Nature in BMC Pharmacology and Toxicology
- Vol. 14 (1) , 12
Open AccessEmpiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study
Previous studies have established a correlation between vancomycin troughs and nephrotoxicity. However, data are currently lacking regarding the effect of guideline-recommended weight-based dosing on nephrotoxicity in methicillin-resistant Staphylococcus aureus bacteremia (MRSAB).
- Open Access
- 27 April 2012
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 12 (1) , 104
Empiric guideline-recommended weight-based vancomycin dosing and mortality in methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study
No studies have evaluated the effect of guideline-recommended weight-based dosing on in-hospital mortality of patients with methicillin-resistant Staphylococcus aureus bacteremia.
- 27 April 2012
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 12 (1) , 104
Open AccessEmpiric guideline-recommended weight-based vancomycin dosing and mortality in methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study
No studies have evaluated the effect of guideline-recommended weight-based dosing on in-hospital mortality of patients with methicillin-resistant Staphylococcus aureus bacteremia.